JRCT ID: jRCT2080220038
Registered date:06/09/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Cardiac edema (CHF) |
Date of first enrollment | 06/09/2005 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : OPC-41061 INN of investigational material : Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Efficacy, safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 79age old |
Gender | Both |
Include criteria | CHF patients with edema, jugular venous distention, hepatomegaly, pulmonary congestion, or 3rd sound due to extracellular volume expansion despite taking oral furosemide, aged between 20 and 80 years, not inclusive, at time of consent |
Exclude criteria |
Related Information
Primary Sponsor | Otsuka Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050038 |
Contact
Public contact | |
Name | |
Address | 03-6361-7314 |
Telephone | |
Affiliation | Otsuka Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |